Results 11 to 20 of about 981 (122)
Mutations in PROSC and vitamin B6 dependent epilepsy – a functional study in zebrafish [PDF]
Background: Vitamin B6 dependent epilepsies are a group of rare, recessive genetic diseases that causes seizures refractory to standard epilepsy treatment but that respond rapidly to vitamin B6. Several disease-causing mutations have already been described in detail, but the mechanism behind one of them, PROSC (proline synthetase co-transcribed homolog)
Selin, Rasmus
core +3 more sources
The ubiquitous pyridoxal 5'-phosphate-binding protein is also an RNA-binding protein. [PDF]
Abstract The pyridoxal 5′‐phosphate binding protein (PLP‐BP) is believed to play a crucial role in PLP homeostasis, which may explain why it is found in living organisms from all kingdoms. Escherichia coli YggS is the most studied homolog, but human PLP‐BP has also attracted much attention because variants of this protein are responsible for a severe ...
Graziani C +9 more
europepmc +2 more sources
MSC Membrane-Coated circPROSC-siRNA Nanoparticles for Ameliorating Craniosynostosis by Inhibiting Premature Suture Ossification. [PDF]
CircPROSC promotes craniosynostosis by sponging miR‐6815‐5p, thereby activating WNT3A/β‐catenin signaling and enhancing RUNX2‐mediated osteogenesis. Targeted silencing of circPROSC with MSC membrane–coated siRNA nanoparticles (MM@Lipo/si‐circPROSC) delivered postnatally into cranial sutures attenuates premature suture closure in Twist1+/– mice ...
Weng Z +6 more
europepmc +2 more sources
Pyridoxal phosphate binding protein (PLPBP) deficiency mimicking opsoclonus-myoclonus-ataxia syndrome. [PDF]
Abstract Introduction Genetic and metabolic conditions can mimic diagnoses such as hypoxic‐ischemic encephalopathy, meningoencephalitis, epilepsy, and opsoclonus‐myoclonus‐ataxia syndrome (OMAS). Without a high index of suspicion and proper testing, diagnoses can be missed, and treatment delayed.
Takle M +6 more
europepmc +2 more sources
Abstract Objective Literature on the genotypic spectrum of Infantile Epileptic Spasms Syndrome (IESS) in children is scarce in developing countries. This multicentre collaboration evaluated the genotypic and phenotypic landscape of genetic IESS in Indian children.
Balamurugan Nagarajan +23 more
wiley +1 more source
Abstract Seizures are common in neonates, but there is substantial management variability. The Neonatal Task Force of the International League Against Epilepsy (ILAE) developed evidence‐based recommendations about antiseizure medication (ASM) management in neonates in accordance with ILAE standards.
Ronit M. Pressler +28 more
wiley +1 more source
On pathways and blind alleys—The importance of biomarkers in vitamin B6‐dependent epilepsies
Abstract Over the past two decades, the field of vitamin B6‐dependent epilepsies has evolved by the recognition of a growing number of gene defects (ALDH7A1, PNPO, ALPL, ALDH4A1, PLPBP as well as defects of the glycosylphosphatidylinositol anchor proteins) that all lead to reduced availability of pyridoxal 5′‐phosphate, an important cofactor in ...
Barbara Plecko
wiley +1 more source
Abstract Although improved treatment could inhibit progression of gastric cancer (GC), the recurrence and metastasis remain challenging issues. Methyltransferase like 13 (METTL13) has been implicated in most human cancers, but its function and mechanism in GC remain elusive.
Qiong Wu +4 more
wiley +1 more source
Abstract The pyridoxal 5′‐phosphate (PLP) homeostasis protein (PLPHP) is a ubiquitous member of the COG0325 family with apparently no catalytic activity. Although the actual cellular role of this protein is unknown, it has been observed that mutations of the PLPHP encoding gene affect the activity of PLP‐dependent enzymes, B6 vitamers and amino acid ...
Angela Tramonti +13 more
wiley +1 more source
Current practice in diagnostic genetic testing of the epilepsies
Abstract Epilepsy genetics is a rapidly developing field, in which novel disease‐associated genes, novel mechanisms associated with epilepsy, and precision medicine approaches are continuously being identified. In the past decade, advances in genomic knowledge and analysis platforms have begun to make clinical genetic testing accessible for, in ...
Ilona Krey +15 more
wiley +1 more source

